Combined regimen of temozolomide and liposomal pegylated doxorubicin in glioblastoma: Toxicity and efficacy - An update

Beier, D. and Hau, P. and Jauch, T. and Beier, C. and Gänßbauer, S. and Glas, M. and Koch, H. and Wismeth, C. and Steinbrecher, A. and Bogdahn, U. (2006) Combined regimen of temozolomide and liposomal pegylated doxorubicin in glioblastoma: Toxicity and efficacy - An update. NEURO-ONCOLOGY, 8 (4). pp. 347-348. ISSN 1522-8517

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Depositing User: Petra Gürster
Date Deposited: 02 Mar 2021 06:05
Last Modified: 02 Mar 2021 06:05
URI: https://pred.uni-regensburg.de/id/eprint/33975

Actions (login required)

View Item View Item